HR Execs on the Move

Brookhaven National Laboratory

www.bnl.gov

 
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nation`s future. Primarily supported by the U.S. Department of Energy`s (DOE) Office of Science, Brookhaven is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 36 R&D 100 Awards, and more than 70 years of pioneering research. Our 2,500-plus staff members lead and support diverse research teams that address the DOE mission to ensure the nation`s security and prosperity by addressing its energy, environmental, and nuclear challenges through transformative science and technology solutions. Brookhaven`s highest-level priorities are nuclear science, energy science, data science, particle physics, accelerator science ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.bnl.gov
  • PO Box 5000
    Upton, NY USA 11973
  • Phone: 631.344.8000

Executives

Name Title Contact Details
Maggie Sullivan
 Chief Human Resources Officer Profile
Paul Pierson
 Chief Procurement Officer Profile
Susan McKeon
 Chief Financial Officer Profile
George Clark
 Chief Financial Officer & Laboratory Associate & Director, Business Services Profile
George Clark
 Chief Financial Officer Profile

Similar Companies

Central Coast Pathology Cnslnt

Central Coast Pathology Cnslnt is a San Luis Obispo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

All State Engineering Testing and Consulting

All State Engineering Testing & Consulting is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Central Medical Lab

Central Medical Lab is a Cypress, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Zai Lab

Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results, Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to not only access the Chinese market but also find a long-term strategic partner for global clinical development. Through these partnerships, Zai Lab has built the strongest late stage oncology portfolio with global first-in-class and/or best-in-class profile, among innovative Chinese biotech companies. We are further supplementing our pipeline with an in-house discovery effort aiming to produce 1-2 global INDs per year. Zai Lab is rapidly expanding into a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing innovative medicines. To that end, we have built our internal R&D center to advance our discovery pipeline, a strong clinical development and operations team, and our own manufacturing facilities in China. We have also established a highly specialized commercial team to support marketing of our innovative products in China. We believe this integrated approach will provide sustainable competitive advantages for Zai Lab. Zai Lab was successfully listed on the Nasdaq Stock Market in September 2017. Since then, Zai Lab significantly expanded with several offices across China and opened its U.S. headquarters in San Francisco in December 2018. As of December 2019, the Company has a global team of approximately 700 employees.

AmeriPath

AmeriPath, Inc. was an anatomic pathology laboratory company and esoteric testing services providers in the United States. The Company was a provider of physician-based anatomic pathology, dermatopathology, molecular diagnostic services, and other